These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 22000706
1. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients. Cho JR, Koo DL, Joo EY, Yoon SM, Ju E, Lee J, Kim DY, Hong SB. Clin Neurophysiol; 2012 May; 123(5):883-91. PubMed ID: 22000706 [Abstract] [Full Text] [Related]
2. Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients. Koo DL, Hwang KJ, Kim D, Kim YJ, Kim JY, Shin W, Kim MR, Joo EY, Lee JM, Hong SB. Eur Neurol; 2013 May; 70(1-2):88-94. PubMed ID: 23839084 [Abstract] [Full Text] [Related]
3. Impact of levetiracetam add-on therapy on different EEG occipital frequencies in epileptic patients. Veauthier J, Haettig H, Meencke HJ. Seizure; 2009 Jul; 18(6):392-5. PubMed ID: 19269864 [Abstract] [Full Text] [Related]
6. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study. López-Góngora M, Martínez-Domeño A, García C, Escartín A. Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572 [Abstract] [Full Text] [Related]
7. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R. Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430 [Abstract] [Full Text] [Related]
8. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Gomer B, Wagner K, Frings L, Saar J, Carius A, Härle M, Steinhoff BJ, Schulze-Bonhage A. Epilepsy Behav; 2007 May; 10(3):486-94. PubMed ID: 17409025 [Abstract] [Full Text] [Related]
9. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M. Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430 [Abstract] [Full Text] [Related]
10. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial. Helmstaedter C, Witt JA. Epilepsy Behav; 2010 May; 18(1-2):74-80. PubMed ID: 20462801 [Abstract] [Full Text] [Related]
11. A prospective study of levetiracetam efficacy in epileptic syndromes with continuous spikes-waves during slow sleep. Atkins M, Nikanorova M. Seizure; 2011 Oct; 20(8):635-9. PubMed ID: 21752673 [Abstract] [Full Text] [Related]
12. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood. von Stülpnagel C, Kluger G, Leiz S, Holthausen H. Epilepsy Behav; 2010 Feb; 17(2):193-8. PubMed ID: 20045383 [Abstract] [Full Text] [Related]
13. Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study. Wu T, Chen CC, Chen TC, Tseng YF, Chiang CB, Hung CC, Liou HH. Epilepsy Behav; 2009 Nov; 16(3):468-74. PubMed ID: 19783219 [Abstract] [Full Text] [Related]
14. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats. van Vliet EA, Edelbroek PM, Gorter JA. Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045 [Abstract] [Full Text] [Related]
15. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy. Specchio N, Boero G, Michelucci R, Gambardella A, Giallonardo AT, Fattouch J, Di Bonaventura C, de Palo A, Ladogana M, Lamberti P, Vigevano F, La Neve A, Specchio LM. Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754 [Abstract] [Full Text] [Related]
16. The effects of levetiracetam on cognition: a non-interventional surveillance study. Helmstaedter C, Witt JA. Epilepsy Behav; 2008 Nov; 13(4):642-9. PubMed ID: 18707022 [Abstract] [Full Text] [Related]
17. Decrease in propagation of interictal epileptiform activity after introduction of levetiracetam visualized with electric source imaging. Larsson PG, Eeg-Olofsson O, Michel CM, Seeck M, Lantz G. Brain Topogr; 2010 Sep; 23(3):269-78. PubMed ID: 20574764 [Abstract] [Full Text] [Related]
18. Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony. Kanemura H, Sano F, Sugita K, Aihara M. Seizure; 2013 Jan; 22(1):43-7. PubMed ID: 23127775 [Abstract] [Full Text] [Related]
19. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy. Rocamora R, Wagner K, Schulze-Bonhage A. Seizure; 2006 Sep; 15(6):428-33. PubMed ID: 16837220 [Abstract] [Full Text] [Related]
20. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study. Peltola J, Peltola M, Auvinen A, Keränen T, Liimatainen S, Kharazmi E, Fallah M. Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]